Latest Als News

Page 5 of 25
OzAurum Resources has reported promising assay results from its James Stage 1 open pit drilling at Mulgabbie North, confirming consistent shallow high-grade gold mineralisation and supporting a near-term, low-cost heap leach development strategy.
Maxwell Dee
Maxwell Dee
13 Jan 2026
Gold Mountain Limited has reported strong assay results from diamond drilling at its Irajuba IR-1 prospect in Brazil, extending known rare earth mineralisation beyond previous targets with notably high magnet rare earth oxide content.
Maxwell Dee
Maxwell Dee
13 Jan 2026
Tambourah Metals has reported impressive high-grade gold intersections at its Tambourah Gold Project in Western Australia, highlighting strong potential for an initial resource estimate. Diamond drilling results confirm continuity of mineralisation at Tambourah King and promising findings at Alexandria and Young Australian prospects.
Maxwell Dee
Maxwell Dee
8 Jan 2026
Magnum Mining has resumed drilling at its Palmares and Azimuth rare earth projects in Brazil, advancing high-grade targets with assay results expected by the end of January.
Maxwell Dee
Maxwell Dee
6 Jan 2026
Patagonia Lithium has reached 335 metres depth in its Formentera lithium brine drilling program in Argentina, successfully collecting brine and core samples for detailed analysis. The company plans further drilling and geophysical surveys to refine its Mineral Resource Estimate.
Maxwell Dee
Maxwell Dee
6 Jan 2026
Neurizon Therapeutics has progressed its ALS treatment NUZ-001 into critical clinical trial phases, even as the FDA declines its Fast Track Designation request pending more data.
Ada Torres
Ada Torres
2 Jan 2026
Alara Resources' joint venture in Oman is under legal scrutiny as local residents seek to halt operations and challenge project licences. The company disputes the claims and continues production while monitoring developments.
Maxwell Dee
Maxwell Dee
31 Dec 2025
Neurizon Therapeutics has launched a A$24.2 million equity raise to fund the next phase of clinical trials for its lead drug NUZ-001 targeting ALS, supported by a global licensing deal and a flexible convertible note facility.
Ada Torres
Ada Torres
23 Dec 2025
Neurizon Therapeutics has locked in a $44 million funding package to fully support its lead drug NUZ-001 in the HEALEY ALS Platform Trial, marking a critical step toward potential regulatory approval and broader neurodegenerative applications.
Ada Torres
Ada Torres
23 Dec 2025
Artemis Resources confirms a significant gold-bearing shear zone at Titan East near its Carlow deposit, highlighted by a wide 19m intersection at 1.6g/t Au and a previous high-grade 5m intercept at 13.1g/t Au. Diamond drilling has commenced to better define this emerging gold system.
Maxwell Dee
Maxwell Dee
19 Dec 2025
Battery Age Minerals has wrapped up its 2025 drilling campaigns at two strategically important projects in Argentina and Austria, setting the stage for assay results that will guide exploration in 2026.
Maxwell Dee
Maxwell Dee
18 Dec 2025
Exultant Mining has launched an aggressive exploration campaign at its Black Hammer Project in New South Wales, collecting 76 rock chip samples and expanding its tenure with a newly granted exploration licence. The company is progressing land access agreements and plans to commence drilling in early 2026.
Maxwell Dee
Maxwell Dee
18 Dec 2025